Toggle navigation
Home
Search
Services
Blog
Contact
About
Produce Rodent Monoclonal Antibodies to Htlv III/Lav
Hwang, Kou M.
Genelabs Technologies, Inc., Redwood City, CA, United States
Search 5 grants from Kou Hwang
Search grants from Genelabs Technologies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Studies to understand and exploit 10-membered enediyne biosynthesis
The Antihypertensive and Lipid-Lowering to Prevent Heart Attack Trial Renewal
Obesity Prev Among Prepubertal African American Girls
Transplantation of Cultured Human Melanocytes as Therapy in Vitiligo
Variability-Aware Software for Efficient Computing with Nanoscale Devices
Recently added grants:
Single-Neuron Marking in the Study of Abnormal Cochleas
Clinical Protocol and Data Management
A novel opioid receptor antagonist for treating abuse and overdose
Protocol Review and Monitoring System
Signaling and Biotechology Program
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Epidemiology And Genetics (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CP061054-001
Application #
3632220
Study Section
Project Start
1986-09-01
Project End
Budget Start
1986-09-11
Budget End
1987-02-28
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Genelabs Technologies, Inc.
Department
Type
DUNS #
City
Redwood City
State
CA
Country
United States
Zip Code
94063
Related projects
NIH 1986
N43 CP
Produce Rodent Monoclonal Antibodies to Htlv III/Lav
Hwang, Kou M. / Genelabs Technologies, Inc.
NIH 1986
N43 CP
Produce Rodent Monoclonal Antibodies to Htlv III/Lav
Hwang, Kou M. / Genelabs Technologies, Inc.
Comments
Be the first to comment on this grant